ClinOption ApS
Private limited companyCVR 42731323DyssegårdActive
ClinOption ApS is a private limited company, based in Dyssegård, active in research and experimental development on natural sciences and engineering, founded in 2021. Net profit fell 43% from 2024 to 2025, ending at DKK 415k.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Gross profit fell 12% (2024 → 2025), to DKK 1.6m.
- Net profit fell 43% (2024 → 2025), to DKK 415k.
- Equity rose 13% (2024 → 2025), to DKK 558k.
Registrations, last 24 months
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2022–2025 · amounts in DKK thousandEquity and net profit
| 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | – |
| Gross profit | 1,650 | 1,835 | 1,808 | 1,584 | −12.4% |
| Operating profit (EBIT) | 897 | 616 | 888 | 611 | −31.2% |
| Profit before tax | 865 | 657 | 935 | 541 | −42.1% |
| Net profit | 667 | 508 | 726 | 415 | −42.8% |
| Total assets | 1,042 | 1,209 | 1,125 | 1,175 | +4.4% |
| Equity | 707 | 627 | 493 | 558 | +13.1% |
| Liabilities | 335 | 582 | 632 | 617 | −2.4% |
| Cash and cash equivalents | 612 | 648 | 632 | 1,104 | +74.6% |
| Average number of employees | 1 | 2 | 1 | 1 | 0% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Annual reports
4 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 10/03/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 06/02/2025 | The company | PDFXBRL |
| 2023 | 01/01/2023 – 31/12/2023 | 29/02/2024 | The company | PDFXBRL |
| 2022 | 29/09/2021 – 31/12/2022 | 29/03/2023 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 35,779of 69,742 Better than 49% | No. 40,888of 69,964 Better than 42% |
| Same industry and fewer than 20 employees329 companies in the comparison | No. 105of 323 Better than 68% | No. 173of 329 Better than 48% |
| Companies that are between 5 and 14 years old33,688 companies in the comparison | No. 19,126of 33,588 Better than 43% | No. 19,237of 33,687 Better than 43% |
| All companies of type ApS66,508 companies in the comparison | No. 34,560of 66,379 Better than 48% | No. 36,796of 66,505 Better than 45% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- ClinOption ApSDKK 1.6m
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- ClinOption ApSDKK 415k
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- ClinOption ApSDKK 558k
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- ClinOption ApS2
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Titi14 HOLDING ApS100%
Management
1 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Tim Dehli Carstensen | Director | 29/09/2021 |
- Founders
- Titi14 HOLDING ApS
Signing rule: Selskabet tegnes af en direktør.
Address and production units
1 active production unitsStjerneborg Alle 11
2870 Dyssegård
| Production unit | Address | Employees | P number |
|---|---|---|---|
| ClinOption ApS | Stjerneborg Alle 11, 1, 2870 Dyssegård | 2 | 1027599903 |
Purpose
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
The purpose is quoted from the register in Danish.
Changes year by year
8 registered events20261 changeaccounts 1
- AccountsAnnual report for 2025 published
20252 changesaccounts 1 · industry 1
- AccountsAnnual report for 2024 published
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
20241 changeaccounts 1
- AccountsAnnual report for 2023 published
20231 changeaccounts 1
- AccountsAnnual report for 2022 published
20213 changesfounded 1 · management 1 · ownership 1
- FoundedRegistered as ClinOption ApS
- ManagementTim Dehli Carstensen appointed director
- OwnershipTiti14 HOLDING ApS registered as owner (100%)
Related companies
Same industry in Gentofte
- Pharmaceutical Research Associates Denmark ApS50 employees
- Novo Nordisk Clinical Innovation Centre A/S32 employees
- Bioporto Diagnostics A/S28 employees
- NIVI Development A/S9 employees
- Bioporto A/S8 employees
- Protein Frontiers ApS4 employees
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.